Novel Treatment-Refractory Preschool Wheeze Phenotypes Identified by Cluster Analysis of Lung Lavage Constituents

W Gerald Teague1, Monica G Lawrence2, Sanford Williams2

  • 1Child Health Research Center, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Va; Division of Respiratory Medicine, Allergy, Immunology, and Sleep, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Va.

Insights

Preschool children with difficult-to-treat wheezing can be categorized into four distinct groups based on airway issues, reflux, viral infections, or inflammation. This research aids in developing targeted therapies for refractory wheeze in young children.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Immunology

Background:

  • Preschool children with treatment-refractory wheeze frequently need emergency care.
  • Current guidelines recommend inhaled corticosteroids, but alternative treatments may be more effective by addressing underlying issues.

Purpose of the Study:

  • To identify distinct patient clusters in preschool children with treatment-refractory wheeze using unsupervised analysis of bronchoalveolar lavage (BAL) variables.
  • To inform the development of targeted therapies for specific wheeze phenotypes.

Main Methods:

  • 155 children aged 6 years or younger underwent bronchoscopy with BAL.
  • Variables were analyzed using factor analysis and clustered with Ward's method, with membership confirmed by discriminant analysis.
  • The model was validated on a separate sample, achieving 86% classification accuracy.

Main Results:

  • Four clusters were identified: 1) early-onset wheeze with structural abnormalities (tracheomalacia) and low IgE; 2) later-onset wheeze with gastroesophageal reflux and increased lipid-laden macrophages; 3) mid-onset wheeze with human rhinovirus transcripts and neutrophilia; 4) older children with high IgE and eosinophilia.

Conclusions:

  • Preschool children with refractory wheeze can be classified into four groups: airway malacia, gastroesophageal reflux, human rhinovirus bronchoalveolitis, and type-2 high inflammation.
  • These findings support the utility of bronchoscopy for diagnosing refractory wheeze and developing novel therapies targeting specific causes like airway malacia, viral infections, and neutrophilia.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
914
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
519
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K